Company Filing History:
Years Active: 2002-2006
Title: Innovations of Alexis Brooks-Walter
Introduction
Alexis Brooks-Walter is a notable inventor based in Birmingham, AL (US). He has made significant contributions to the field of medical research, particularly in the development of pneumococcal vaccines. With a total of 4 patents, his work has the potential to impact public health positively.
Latest Patents
One of his latest patents focuses on Pneumococcal surface protein C (PspC), which includes the identification of epitopic regions and strain selection. This patent discloses and claims various aspects of PspC, including isolated nucleic acid molecules that encode fragments or portions of PspC. The invention also outlines methods for detecting PspC in samples through amplification techniques, such as polymerase chain reaction. Furthermore, it discusses the formulation of immunological and vaccine compositions that incorporate PspC, either alone or in combination with other pneumococcal antigens.
Career Highlights
Throughout his career, Alexis has worked with esteemed organizations, including the UAB Research Foundation and the University of Alabama. His research has been pivotal in advancing the understanding of pneumococcal diseases and developing effective vaccines.
Collaborations
Alexis has collaborated with notable colleagues, including David E. Briles and Susan K. Hollingshead, who have contributed to his research endeavors.
Conclusion
Alexis Brooks-Walter's innovative work in the field of pneumococcal research exemplifies the impact of dedicated inventors on public health. His patents and collaborations continue to pave the way for advancements in vaccine development.